Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP169949.RACgNzVJEaBrhb1O4z6rdL7WXDr-5w3bO56KFeBE2593Y130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP169949.RACgNzVJEaBrhb1O4z6rdL7WXDr-5w3bO56KFeBE2593Y130_assertion type Assertion NP169949.RACgNzVJEaBrhb1O4z6rdL7WXDr-5w3bO56KFeBE2593Y130_head.
- NP169949.RACgNzVJEaBrhb1O4z6rdL7WXDr-5w3bO56KFeBE2593Y130_assertion description "[Inhibition of active Ras by farnesylthiosalicylic acid led to attenuation of the Raf-MEK-ERK and phosphoinositide 3-kinase-Akt-glycogen synthase-3 (GSK-3) pathways, to reduction in cyclin D1, phospho-retinoblastoma, and E2F, and to increase in the cyclin-dependent kinase inhibitor p27 and in retinoblastoma-binding protein-1, an inhibitor of E2F transcriptional activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP169949.RACgNzVJEaBrhb1O4z6rdL7WXDr-5w3bO56KFeBE2593Y130_provenance.
- NP169949.RACgNzVJEaBrhb1O4z6rdL7WXDr-5w3bO56KFeBE2593Y130_assertion evidence source_evidence_literature NP169949.RACgNzVJEaBrhb1O4z6rdL7WXDr-5w3bO56KFeBE2593Y130_provenance.
- NP169949.RACgNzVJEaBrhb1O4z6rdL7WXDr-5w3bO56KFeBE2593Y130_assertion SIO_000772 15958613 NP169949.RACgNzVJEaBrhb1O4z6rdL7WXDr-5w3bO56KFeBE2593Y130_provenance.
- NP169949.RACgNzVJEaBrhb1O4z6rdL7WXDr-5w3bO56KFeBE2593Y130_assertion wasDerivedFrom befree-20140225 NP169949.RACgNzVJEaBrhb1O4z6rdL7WXDr-5w3bO56KFeBE2593Y130_provenance.
- NP169949.RACgNzVJEaBrhb1O4z6rdL7WXDr-5w3bO56KFeBE2593Y130_assertion wasGeneratedBy ECO_0000203 NP169949.RACgNzVJEaBrhb1O4z6rdL7WXDr-5w3bO56KFeBE2593Y130_provenance.